News Quantified

TBPH – theravance biopharma, inc. - ordinary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Vicinitas Therapeutics Appoints Adam Hughes as Chief Scientific Officer [Yahoo! Finance]

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024

Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength? [Yahoo! Finance]

Theravance Biopharma, Inc. (NASDAQ: TBPH) is now covered by analysts at BTIG Research. They set a "buy" rating and a $21.00 price target on the stock.

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024 [Yahoo

5.0%

MISS

7.4%

BEAT

-0.9%

MISS

0.4%

BEAT

Form SC 13G/A Theravance Biopharma, Filed by: Madison Avenue Partners, LP

Form 4 Theravance Biopharma, For: May 01 Filed by: Samaha Eli

Form DEF 14A Theravance Biopharma, For: May 08

Form 4 Theravance Biopharma, For: Apr 02 Filed by: Winningham Rick E

Form 4 Theravance Biopharma, For: Apr 02 Filed by: Sawaf Aziz

Top News Gainers

11/26 Theravance Biopharma to Present at Two Upcoming Investor Conferences 10.0%

4/9 Form 8-K Theravance Biopharma, For: Apr 09 5.1%

7/31 Q2/2019 6/30/2019 EPS -0.720 ZacksConsensus -1.220 ActVsEst 0.500 - Beat 4.8%

3/23 Stocks To Watch: Theravance Biopharma Sees Relative Strength Rating Jump To 94 [Investor's Business Daily] 4.7%

3/2 Theravance Biopharma Announces Closing of Private Placement of $400 Million Non-Recourse Notes 4.4%

4/20 Theravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and Colitis 4.1%

4/23 Theravance Biopharma Announces First Subject Dosed in Phase 1 Study of TD-0903, in Development for the Treatment of Hospitalized Patients with Acute Lung Injury Caused by COVID-19 3.9%

7/25 Theravance Biopharma to Report Second Quarter 2019 Financial Results on July 31 3.8%

11/6 Theravance Biopharma to Present at the 2019 Credit Suisse Healthcare Conference 3.6%

1/30 Theravance Biopharma Inc (NASDAQ: TBPH) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 3.6%

Top News Decliners

2/11 Theravance Biopharma Announces Pricing of Public Offering of Ordinary Shares -11.5%

5/7 Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update -9.6%

4/30 Form 4 Theravance Biopharma, For: Apr 28 Filed by: YOUNG WILLIAM D -8.3%

9/25 Theravance Biopharma to Present at the 2019 Cantor Global Healthcare Conference -7.7%

2/10 Theravance Biopharma Announces Proposed Public Offering of Ordinary Shares -7.4%

3/24 Form DEF 14A Theravance Biopharma, For: Apr 28 -5.4%

4/29 Form 8-K Theravance Biopharma, For: Apr 28 -5.0%

5/22 Form 4 Theravance Biopharma, For: May 20 Filed by: WORBOYS PHILIP D -4.9%

6/14 Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories -4.8%

5/18 Theravance Biopharma Inc (NASDAQ: TBPH) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -3.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day